Target intelligence / Profile preview

Ribosomal protein L13a pseudogene 5 (RPL13AP5)

Target
RPL13AP5
Molecular classification
Other (Pseudogene)
01

Overview

RPL13AP5 (Ribosomal protein L13a pseudogene 5) is a processed pseudogene related to the functional RPL13A gene, which encodes ribosomal protein L13a, a component of the 60S ribosomal subunit. RPL13AP5 does not produce a functional protein and has no established biological function or clinical relevance. Like other pseudogenes, it originated from the duplication or retrotransposition of the parent gene and may be present as a non-coding genomic segment. It has been included in select gene expression and genome annotation databases, but is neither a therapeutic target nor a clinically actionable entity. If a structured or druggable molecular target (for example, RPL13A itself) is required, RPL13AP5 should be disregarded in favor of the canonical protein-encoding gene.

Other names
bA196N24.2RPL13A_8_1086BA196N24.2
02

Mechanism of action

None (not a functional or druggable target)

03

Biological functions

None (pseudogenes are generally non-functional and do not encode active proteins; no known biological function)
04

Disease associations

None established (there are no associated diseases or proven disease mechanisms involving RPL13AP5)
05

Safety considerations

None (no therapeutic use or relevance)
06

Interacting drugs

None (there are no drugs known to interact with RPL13AP5, as it does not encode a functional protein)
07

Biomarkers

None (not used as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Ribosomal protein L13a pseudogene 5 (RPL13AP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13a pseudogene 5 (RPL13AP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call